421 related articles for article (PubMed ID: 32416701)
41. Dual active 1, 4-dihydropyridine derivatives: Design, green synthesis and in vitro anti-cancer and anti-oxidant studies.
Anaikutti P; Makam P
Bioorg Chem; 2020 Dec; 105():104379. PubMed ID: 33113411
[TBL] [Abstract][Full Text] [Related]
42. Synthesis and biological evaluation of 2-styrylquinolines as antitumour agents and EGFR kinase inhibitors: molecular docking study.
El-Sayed MA; El-Husseiny WM; Abdel-Aziz NI; El-Azab AS; Abuelizz HA; Abdel-Aziz AA
J Enzyme Inhib Med Chem; 2018 Dec; 33(1):199-209. PubMed ID: 29251017
[TBL] [Abstract][Full Text] [Related]
43. Synthesis and in vitro anticancer evaluation of some fused indazoles, quinazolines and quinolines as potential EGFR inhibitors.
Abdelsalam EA; Zaghary WA; Amin KM; Abou Taleb NA; Mekawey AAI; Eldehna WM; Abdel-Aziz HA; Hammad SF
Bioorg Chem; 2019 Aug; 89():102985. PubMed ID: 31121559
[TBL] [Abstract][Full Text] [Related]
44. Potent human dihydroorotate dehydrogenase inhibitory activity of new quinoline-4-carboxylic acids derived from phenolic aldehydes: Synthesis, cytotoxicity, lipophilicity and molecular docking studies.
Petrović MM; Roschger C; Chaudary S; Zierer A; Mladenović M; Jakovljević K; Marković V; Botta B; Joksović MD
Bioorg Chem; 2020 Dec; 105():104373. PubMed ID: 33074120
[TBL] [Abstract][Full Text] [Related]
45. Evaluation of Biological Activities of Twenty Flavones and In Silico Docking Study.
Belaiba M; Aldulaijan S; Messaoudi S; Abedrabba M; Dhouib A; Bouajila J
Molecules; 2023 Mar; 28(6):. PubMed ID: 36985391
[TBL] [Abstract][Full Text] [Related]
46. Carboxylate derivatives of tributyltin (IV) complexes as anticancer and antileishmanial agents.
Waseem D; Butt AF; Haq IU; Bhatti MH; Khan GM
Daru; 2017 Apr; 25(1):8. PubMed ID: 28376844
[TBL] [Abstract][Full Text] [Related]
47. New pyrimidine-benzoxazole/benzimidazole hybrids: Synthesis, antioxidant, cytotoxic activity, in vitro cyclooxygenase and phospholipase A2-V inhibition.
Abdelgawad MA; Bakr RB; Ahmad W; Al-Sanea MM; Elshemy HAH
Bioorg Chem; 2019 Nov; 92():103218. PubMed ID: 31536956
[TBL] [Abstract][Full Text] [Related]
48. Synthesis and antiproliferative activity of 6,7-disubstituted-4-phenoxyquinoline derivatives bearing the 1,8-naphthyridin-2-one moiety.
Tang Q; Duan Y; Xiong H; Chen T; Xiao Z; Wang L; Xiao Y; Huang S; Xiong Y; Zhu W; Gong P; Zheng P
Eur J Med Chem; 2018 Oct; 158():201-213. PubMed ID: 30216852
[TBL] [Abstract][Full Text] [Related]
49. Synthesis and cytotoxicity of 2-methyl-1-substituted-imidazo [4,5-g]quinoline-4,9-dione and 7,8-dihydro-10H-[1,4]oxazino[3',4':2,3]imidazo[4,5-g]quinoline-5,12-dio ne derivatives.
Suh ME; Kang MJ; Yoo HW; Park SY; Lee CO
Bioorg Med Chem; 2000 Aug; 8(8):2079-83. PubMed ID: 11003153
[TBL] [Abstract][Full Text] [Related]
50. Synthesis, antimicrobial, antioxidant, cytotoxic, antiurease and molecular docking studies of N-(3-trifluoromethyl)benzoyl-N'-aryl thiourea derivatives.
Maalik A; Rahim H; Saleem M; Fatima N; Rauf A; Wadood A; Malik MI; Ahmed A; Rafique H; Zafar MN; Riaz M; Rasheed L; Mumtaz A
Bioorg Chem; 2019 Jul; 88():102946. PubMed ID: 31054433
[TBL] [Abstract][Full Text] [Related]
51. Design, synthesis and biological evaluation of novel benzo- and tetrahydrobenzo-[h]quinoline derivatives as potential DNA-intercalating antitumor agents.
Jafari F; Baghayi H; Lavaee P; Hadizadeh F; Soltani F; Moallemzadeh H; Mirzaei S; Aboutorabzadeh SM; Ghodsi R
Eur J Med Chem; 2019 Feb; 164():292-303. PubMed ID: 30599418
[TBL] [Abstract][Full Text] [Related]
52. Design, synthesis, molecular docking, and anticancer evaluations of 1-benzylquinazoline-2,4(1H,3H)-dione bearing different moieties as VEGFR-2 inhibitors.
El-Adl K; El-Helby AA; Sakr H; El-Hddad SSA
Arch Pharm (Weinheim); 2020 Aug; 353(8):e2000068. PubMed ID: 32510731
[TBL] [Abstract][Full Text] [Related]
53. Facile One-Pot Synthesis of Tellurium Nanorods as Antioxidant and Anticancer Agents.
Huang W; Wu H; Li X; Chen T
Chem Asian J; 2016 Aug; 11(16):2301-11. PubMed ID: 27325381
[TBL] [Abstract][Full Text] [Related]
54. Quinoline-based promising anticancer and antibacterial agents, and some metabolic enzyme inhibitors.
Ökten S; Aydın A; Koçyiğit ÜM; Çakmak O; Erkan S; Andac CA; Taslimi P; Gülçin İ
Arch Pharm (Weinheim); 2020 Sep; 353(9):e2000086. PubMed ID: 32537757
[TBL] [Abstract][Full Text] [Related]
55. Design and synthesis of new RAF kinase-inhibiting antiproliferative quinoline derivatives. Part 2: Diarylurea derivatives.
El-Gamal MI; Khan MA; Tarazi H; Abdel-Maksoud MS; Gamal El-Din MM; Yoo KH; Oh CH
Eur J Med Chem; 2017 Feb; 127():413-423. PubMed ID: 28088086
[TBL] [Abstract][Full Text] [Related]
56. Synthesis and In Vitro Evaluation of Tetrahydroquinoline Derivatives as Antiproliferative Compounds of Breast Cancer via Targeting the GPER.
Zacarías-Lara OJ; Méndez-Luna D; Martínez-Ruíz G; García-Sanchéz JR; Fragoso-Vázquez MJ; Bello M; Becerra-Martínez E; García-Vázquez JB; Correa-Basurto J
Anticancer Agents Med Chem; 2019; 19(6):760-771. PubMed ID: 30451119
[TBL] [Abstract][Full Text] [Related]
57. Identification of 3-Bromo-1-Ethyl-1H-Indole as a Potent Anticancer Agent with Promising Inhibitory Effects on GST Isozymes.
Yılmaz C; Arslan S; Mutlu D; Konus M; Kayhan A; Kurt-Kızıldoğan A; Otur Ç; Ozok O; Kivrak A
Anticancer Agents Med Chem; 2021; 21(10):1292-1300. PubMed ID: 32951581
[TBL] [Abstract][Full Text] [Related]
58. Design, synthesis and biological evaluation of new quinoline derivatives as potential antitumor agents.
Su T; Zhu J; Sun R; Zhang H; Huang Q; Zhang X; Du R; Qiu L; Cao R
Eur J Med Chem; 2019 Sep; 178():154-167. PubMed ID: 31181480
[TBL] [Abstract][Full Text] [Related]
59. Design, Synthesis, and Anticancer Activity Studies of Novel Quinoline-Chalcone Derivatives.
Guan YF; Liu XJ; Yuan XY; Liu WB; Li YR; Yu GX; Tian XY; Zhang YB; Song J; Li W; Zhang SY
Molecules; 2021 Aug; 26(16):. PubMed ID: 34443487
[TBL] [Abstract][Full Text] [Related]
60. New quinoline/chalcone hybrids as anti-cancer agents: Design, synthesis, and evaluations of cytotoxicity and PI3K inhibitory activity.
Abbas SH; Abd El-Hafeez AA; Shoman ME; Montano MM; Hassan HA
Bioorg Chem; 2019 Feb; 82():360-377. PubMed ID: 30428415
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
